Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09ZFF
|
||||
Former ID |
DIB008199
|
||||
Drug Name |
HRC-101
|
||||
Synonyms |
Oxygain; HML-109
|
||||
Indication | Blood transfusion [ICD10:D50-D89] | Terminated | [547440] | ||
Company |
Ontario Inc
|
||||
Target and Pathway | |||||
Target(s) | Hemoglobin | Target Info | Modulator | [528970] | |
KEGG Pathway | African trypanosomiasis | ||||
Malaria | |||||
WikiPathways | Binding and Uptake of Ligands by Scavenger Receptors | ||||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | |||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes | |||||
Factors involved in megakaryocyte development and platelet production | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.